VCYT Stock Analysis Today
Updated Nov 7, 2026 · trends, key levels, insider activity and news
Is VCYT bullish or bearish today?
Daily trend: Uptrend (confirmed) — turns down below $41.22
SEPT signal: Institutional Drive · Strong Bullish
Research grade: B+ · fair value $66.13 (+118.2%)
VCYT trend by timeframe
| Daily | Uptrend (confirmed) |
|---|---|
| 4 hour | Expanding |
| 1 hour | Strong Bearish |
| 15 min | Symmetric Triangle |
| 5 min | Strong Bearish |
Trends are calculated from price structure and update during market hours.
VCYT support and resistance levels
Resistance (above)
$28.2552 touches
$31.9544 touches
$35.1910 touches
Support (below)
—
Upside zones: $33.73 / $35.70 / $37.67
See all levels on the live chart →Insider and institutional activity
Insiders
Sell30-day buys / sells
0 / 1930-day net
-$1.2MHedge fund holders
311Latest VCYT news and filings
- EarningsFiscal.ai
Veracyte, Inc. Posts Third Quarter 2026 Earnings
Veracyte, Inc. released its quarterly numbers for the three months ending in 2026's third quarter. The filing covers the diagnostics company's performance for that period.
- EarningsBenzinga
Veracyte Discusses Third-Quarter 2026 Results on Conference Call
Veracyte hosted a call covering its financial performance for the third quarter of 2026, and a written record of the discussion is available.
- NewsBenzinga
Veracyte announces $100M share buyback plan
Veracyte said it will repurchase up to $100 million of its own stock. A buyback can reduce the number of shares outstanding.
- GuidanceBenzinga
Veracyte trims FY2026 sales outlook to $590M-$593M
Veracyte narrowed its full-year 2026 revenue forecast to a range of $590 million to $593 million. The prior range was $590 million to $596 million, and analysts had expected $593.894 million.
- EarningsBenzinga
Veracyte posts Q3 adjusted profit of $0.51 per share, topping $0.41 consensus
Veracyte's third-quarter adjusted earnings came in at $0.51 per share, ahead of the $0.41 analysts expected. Revenue of $151.754 million also exceeded the $147.439 million consensus.
- SEC FilingSECVeracyte, Inc. filed an insider trading report (Form 4)
Form 4 reports shares bought or sold by company insiders such as officers, directors or large holders.
Live VCYT chart with trend icons on every timeframe, key levels, dark pool and options flow, news alerts, and Ask GOAX for a full analysis on demand.
Start free 7-day trialFrequently asked questions
Is VCYT bullish or bearish today?
VCYT daily trend: Uptrend (confirmed) — turns down below $41.215. SEPT signal: Institutional Drive (Strong Bullish). Updated Nov 7, 2026.
What is VCYT's trend on each timeframe?
Daily: Uptrend (confirmed); 4 hour: Expanding; 1 hour: Strong Bearish; 15 min: Symmetric Triangle; 5 min: Strong Bearish.
What are VCYT support and resistance levels?
Resistance: $28.25, $31.95, $35.19. Last price $24.16.
Are insiders buying or selling VCYT?
Insider signal: Sell. Last 30 days: 0 buys, 19 sells, net -$1.2M. 311 hedge funds hold VCYT.
What is the latest news on VCYT?
Nov 4, 2026: Veracyte, Inc. Posts Third Quarter 2026 Earnings · Nov 4, 2026: Veracyte Discusses Third-Quarter 2026 Results on Conference Call · Nov 4, 2026: Veracyte announces $100M share buyback plan